Intracytoplasmatic Sperm Injection using testicular spermatozoa in men with azoospermia; an observational study with follow-up of the offspring.

Intracytoplasmatic Sperm Injection using testicular spermatozoa in men with azoospermia; an observational study with follow-up of the offspring. - TESE in the Netherlands

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35132

Enrollment

2065

Registered

2006-10-19

Start date

2007-06-27

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

birthdefect congenital malformations

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Azoospermia, trying to conceive

Exclusion criteria

Exclusion criteria: Contraindication for ICSI treatment

Design outcomes

Primary

Measure	Time frame
Percentage congenital malformations, neurological- and behaviour problems in children born after TESE	—

Secondary

Measure	Time frame
- The percentage of TESE procedures in which usuable spermatozoa are found (the sperm retrieval rate [SRR]) - The number of ICSI procedures per TESE - The fertilization rate - Clinical pregnancy per patient with a azoospermia - Ongoing pregnancy rate per patient with a azoospermia - Ongoing pregnancies per TESE procedure - Number of life births per TESE - Clinical pregnancy rate per ICSI cycle - Ongoing pregnancy rate per ICSI cycle - Miscarriage rate per ICSI cycle - Complications after TESE: infection, bleeding, pain and decrease of testosterone level	—

Measure

Time frame

- The percentage of TESE procedures in which usuable spermatozoa are found (the sperm retrieval rate [SRR]) - The number of ICSI procedures per TESE - The fertilization rate - Clinical pregnancy per patient with a azoospermia - Ongoing pregnancy rate per patient with a azoospermia - Ongoing pregnancies per TESE procedure - Number of life births per TESE - Clinical pregnancy rate per ICSI cycle - Ongoing pregnancy rate per ICSI cycle - Miscarriage rate per ICSI cycle - Complications after TESE: infection, bleeding, pain and decrease of testosterone level

—

Countries

Netherlands

Outcome results